DNA Oyj - Company Announcement

DNA Oyj: Stabilisation measures taken

DNA OYJ STOCK EXCHANGE RELEASE 9 DECEMBER 2016, 8.00 pm EET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN,
NEW ZEALAND, SOUTH AFRICA OR SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE
RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

This document is an announcement and not a prospectus for the purposes of
applicable measures implementing EU Directive 2003/71/EC as amended (such
Directive, together with any applicable implementing measures of the relevant
Member State under such Directive, the "Prospectus Directive") and as such does
not constitute an offer to sell or the solicitation of an offer to purchase
securities. A prospectus has been prepared pursuant to the Prospectus Directive
in connection with the listing of the Company's shares on Nasdaq Helsinki Ltd.

Stabilisation measures taken

With reference to the offering circular published by DNA Oyj ("DNA", "Company")
on 14 November 2016 and company announcement dated on 29 November 2016 regarding
the result of the initial public offering of DNA (the "Offering"), DNA has
received notification that Danske Bank A/S, Helsinki branch ("Danske"), acting
as stabilising manager in the Offering, has carried out stabilisation measures
between 30 November 2016 and 9 December 2016.

Danske (contact: Jens Plenov, tel: +442074108000) has announced that it has
performed stabilisation measures (in accordance with Article 3.2(d) of the EU
Market Abuse Regulation (EU) No. 596/2014) on Nasdaq Helsinki in accordance with
what is set out below.

+----------------------------------------------------------+
|Stabilisation Information                                 |
+---------------------+------------------------------------+
|Issuer               |DNA Plc                             |
+---------------------+------------------------------------+
|Securities           |Ordinary Shares (ISIN: FI4000062385)|
+---------------------+------------------------------------+
|Offering size        |46,991,750 Shares                   |
+---------------------+------------------------------------+
|Offer price          |EUR 10.10 per Share                 |
+---------------------+------------------------------------+
|Ticker               |DNA                                 |
+---------------------+------------------------------------+
|Stabilisation manager|Danske Bank A/S, Helsinki branch    |
+---------------------+------------------------------------+

+------------------------------------------------------------------------------+
|Stabilisation Transactions                                                    |
+----------+-----------+------------+------------+---------+--------+----------+
|Date      |Price      |Price       |Price       |Quantity |Currency|Market    |
|          |(lowest)   |(highest)   |(weighted   |         |        |          |
|          |           |            |average)    |         |        |          |
+----------+-----------+------------+------------+---------+--------+----------+
|30-11-2016|10.10      |10.10       |10.10       |1,131,304|EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|01-12-2016|10.01      |10.10       |10.08       |610,710  |EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|02-12-2016|9.90       |10.10       |10.02       |1,163,636|EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|05-12-2016|10.01      |10.10       |10.06       |53,604   |EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|07-12-2016|10.10      |10.10       |10.10       |82,766   |EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|08-12-2016|10.08      |10.10       |10.10       |125,125  |EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+
|09-12-2016|10.10      |10.10       |10.10       |59,021   |EUR     |Nasdaq    |
|          |           |            |            |         |        |Helsinki  |
+----------+-----------+------------+------------+---------+--------+----------+

Further enquiries
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi

Disclaimer
The information contained herein does not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of the securities
referred to herein in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration, exemption from registration or
qualification under the securities laws of any jurisdiction.

This document is not an offer for sale nor a solicitation of an offer to buy any
securities in the United States (including any of its states, its territories
and possessions and the District of Columbia). These materials are not for
distribution, directly or indirectly, in or into the United States. The
securities referred to herein (the "Securities") have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act") or the laws of any state of the United States. Consequently, the
Securities may not be offered, sold, pledged or otherwise transferred directly
or indirectly in or into the United States except in accordance with the
registration requirements of the Securities Act or an exemption therefrom. No
public offering of the Securities is being made in the United States.

This document is an announcement and not a prospectus for the purposes of
applicable measures implementing EU Directive 2003/71/EC as amended (such
Directive, together with any applicable implementing measures of the relevant
Member State under such Directive, the "Prospectus Directive") and as such does
not constitute an offer to sell or the solicitation of an offer to purchase
securities. A prospectus has been prepared pursuant to the Prospectus Directive
in connection with the listing of the Company's shares on Nasdaq Helsinki Ltd
(the "Prospectus").

A prospectus prepared pursuant to the Prospectus Directive and the Finnish
Securities Markets Act (746/2012, as amended) on the public offering of
securities and the admission of securities to trading on a regulated market (the
"Prospectus Law") has been made available in accordance with the requirements of
the Prospectus Directive and the Prospectus Law in Finland and can be obtained
from the Company and other places indicated in the Prospectus.

The securities referred to herein are not and will not be publicly offered, sold
or registered, in any jurisdiction other than Finland. Any offer of securities
to the public that may be deemed to be made pursuant to this communication in
any EEA Member State other than Finland is addressed solely to qualified
investors (within the meaning of the Prospectus Directive) in that Member State.

Danske Bank A/S, Helsinki branch acts exclusively for the Company and for no-one
else and will not regard any other person (whether or not a recipient of this
announcement) as a client and will not be responsible to any other person for
providing the protections afforded to its respective clients, or for advising
any such person on the contents of this announcement or in connection with any
transaction referred to in this announcement.

This announcement does not constitute a recommendation concerning the shares of
DNA. The price and value of securities and any income from them can go down as
well as up. Past performance is not a guide to future performance. Information
in this announcement or any of the documents relating to the offering cannot be
relied upon as a guide to future performance.

No representation or warranty, express or implied, is given by or on behalf of
Danske Bank A/S, Helsinki branch or any of its respective subsidiaries,
affiliates, agents or advisers or any of such persons' affiliates, directors,
officers or employees or any other person as to the fairness, truth, accuracy,
completeness or verification of the information or the opinions contained in
this announcement (or whether any information has been omitted from the
announcement) or any other information relating to the Company, its subsidiaries
or associated companies, whether written, oral or in a visual or electronic
form, and howsoever transmitted or made available, and no liability is accepted
for any such information, omissions or opinions. Danske Bank A/S, Helsinki
branch or any of its respective subsidiaries, affiliates, agents or advisers or
any of such persons' affiliates, directors, officers or employees or any other
person disclaim any and all responsibility and liability whatsoever, whether
arising in tort, contract or otherwise, for any errors, omissions or
inaccuracies in such information or opinions or for any loss, cost or damage
suffered or incurred howsoever arising, directly or indirectly, from any use of
this announcement or its contents or otherwise in connection with this
announcement.

This communication does not constitute an offer of the Securities to the public
in the United Kingdom. No prospectus has been or will be approved in the United
Kingdom in respect of the Securities. This communication is being distributed to
and is directed only at (i) persons who are outside the United Kingdom or (ii)
persons who are investment professionals within the meaning of Article 19(5) of
the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005
(the "Order") and (iii) high net worth entities, and other persons to whom it
may lawfully be communicated, falling within Article 49(2)(a) to (d) of the
Order (all such persons together being referred to as "Relevant Persons"). Any
investment activity to which this communication relates will only be available
to and will only be engaged with, Relevant Persons. Any person who is not a
Relevant Person should not act or rely on this document or any of its contents.

Shares in the Company have not been and will not be registered under the
applicable securities laws of Australia, Canada, Hong Kong, Japan, New Zealand,
South Africa or Singapore and, subject to certain exceptions, may not be offered
or sold within Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or
Singapore or to, or for the account or benefit of, citizens or residents of
Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or Singapore
except under circumstances which will result in full compliance with the
applicable laws and regulations promulgated by the relevant regulatory
authorities in effect at the relevant time.

After the Offering, the Danske Bank Helsinki A/S may, but is not obligated to,
within 30 days from the commencement of trading of the DNA's shares on the
Helsinki Stock Exchange (the "Stabilization Period"), engage in measures which
stabilize, maintain or otherwise affect the price of DNA's shares. These
measures may raise or maintain the market price of the shares in comparison with
the price levels determined independently on the market or may prevent or delay
any decrease in the market price of the shares. The Stabilizing Manager has no
obligation to carry out these measures, and they may stop any of these measures
at any time. The Stabilizing Manager or the Company on behalf of the Stabilizing
Manager will publish information regarding the stabilization required by
legislation or other applicable regulations at the end of stabilization period.

[]